Jacob Minnig
Jacob Minnig
"The New Era of Ketamine Therapy" Interview with Dr. Christopher Fischer, MD and Dr. Sofia Peeva, MD
"The New Era of Ketamine Therapy" Interview with Dr. Christopher Fischer, MD and Dr. Sofia Peeva, MD
"The New Era of Ketamine Therapy" Interview with Dr. Christopher Fischer, MD and Dr. Sofia Peeva, MD
Thursday 8th December 2022
Discover how ketamine therapy is revolutionizing mental health treatment in this episode with Dr. Christopher Fischer and Dr. Sofia Peeva.
Explicit
92 minutes
Informative
Hopeful
Transformative
Engaging
Thought-provoking
About this podcast
Author:
Jacob Minnig
Overview:
Categories:
Innovative Treatments & Recovery Paths
Sobriety Toolkit
Innovative Healing Arts
Mindfulness & Emotional Wellbeing
Navigating Intimate Relationships
Links:
Visit site
Episodes:
131 (View all)
Do you want to link to this podcast?
Get the buttons here!Ketamine Therapy: A New Frontier in Mental Health Treatment
I think we need to go back to kind of like this ancient medicine a little bit where we use what our planet kind of provides us and tap into it, versus just stuffing ourselves with all these pills that the pharmaceuticals make, because those pills. And that really gets back to something that we talked to all our patients about: is that our treatment is a catalyst.
Imagine a treatment that offers new hope for those grappling with depression, anxiety, trauma, and mood disorders. That's exactly what Dr. Christopher Fischer and Dr. Sofia Peeva discuss in this episode of 'Behavioral Health Integration'. Hosted by Jacob Minnig, the episode dives into the transformative potential of ketamine-assisted therapy. Dr. Fischer and Dr. Peeva share their personal journeys into the medical field and their initial encounters with ketamine as a treatment option.
They highlight how Propel Therapeutics admits patients and the criteria for qualifying for ketamine therapy. The conversation doesn't stop there; they also explore the entire treatment process, from initial preparation to post-infusion integration therapy. But ketamine isn't a magic bullet. The doctors emphasize that it's not suitable for everyone but can be incredibly effective for certain individuals. They delve into the benefits, such as reduced amygdala activation and increased mindfulness, which can make a world of difference for patients.
Looking ahead, Dr. Fischer and Dr. Peeva discuss the future landscape of ketamine therapy, including potential collaborations with other clinics and what this could mean for patients and health insurance. This episode is a must-listen for anyone interested in cutting-edge mental health treatments, offering valuable insights into a promising new therapy.